Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by slowing stomach emptying and reducing hunger signals in the brain, leading to consistent weight loss that builds over time. Most patients see meaningful results between weeks 4 and 8, though the rate varies significantly based on individual factors. Understanding realistic expectations helps you stay motivated and recognize whether your treatment is working as intended.
Typical Weekly Weight Loss Patterns on Semaglutide
Clinical trials show semaglutide produces an average loss of 1 to 1.5 pounds per week during the dose-escalation phase, which typically spans 16 to 20 weeks. In the STEP trials (the largest semaglutide research studies), participants on the highest maintenance doses lost 10% to 15% of their starting body weight over one year. Weekly loss is not linear—some weeks show bigger drops, while others plateau as your body adjusts to lower calorie intake.
The first two weeks often bring the largest initial decline, partly from water weight and reduced food volume in your digestive system. After the initial response, weekly loss tends to stabilize at a slower, steadier pace. This pattern is normal and reflects your body adapting to sustained appetite suppression rather than a sign that the medication is losing effectiveness.
Factors That Influence Your Individual Weekly Loss Rate
Your starting weight is the strongest predictor of early weight loss speed. Patients beginning treatment at higher body weights often see faster absolute weekly losses in the first 8 to 12 weeks. Your metabolism, age, physical activity level, and how strictly you follow reduced-calorie eating also shape results—semaglutide suppresses appetite, but it does not eliminate the need for mindful food choices.
Genetic variation in GLP-1 receptor sensitivity and other peptide pathways affects how your body responds to treatment. PlexusDx offers the Precision Peptide Genetic Test, which maps 49 peptides across 14 metabolic pathways and identifies genetic variants like GLP1R rs6923761 that influence your unique weight-loss trajectory. Understanding your genetic predispositions helps your provider optimize your dose and combination strategy for faster, more sustainable results.
Medication adherence and dose consistency matter significantly. Skipping doses or not increasing your dose as prescribed will slow progress. Your provider may adjust your dose every 4 weeks during the escalation phase to maximize effectiveness while minimizing side effects.
Monthly Milestones: What to Expect in Your First Year
Weeks 1–4: Initial appetite suppression begins, and you may notice reduced food cravings and smaller portion sizes. Total weight loss is often 2 to 5 pounds, though some of this reflects decreased fluid and food bulk rather than fat loss alone.
Weeks 5–12: Steady weekly losses of 1 to 2 pounds become more apparent. By the end of 12 weeks, many patients report 8 to 15 pounds lost. Energy levels often improve, and clothes may fit noticeably differently.
Months 4–6: Loss may slow slightly as your body reaches a lower stable weight. Weekly losses often settle at 0.5 to 1 pound. This is not a plateau—it reflects the natural deceleration as your calorie deficit becomes smaller relative to your body weight.
How PlexusDx Personalization Optimizes Your Weekly Results
PlexusDx delivers semaglutide from licensed 503A compounding pharmacies, ensuring quality and consistency. Your dose may need to go up. Your price won't—Compounded Semaglutide Injection starts at $149 per month flat across all three commitment tiers, with no flat per-compound pricing increases.
Genetic testing and metabolic profiling allow PlexusDx providers to identify whether you respond better to semaglutide alone or benefit from combination therapy like GLP-Squared Injection (semaglutide plus tirzepatide). Early genetic insights mean faster personalization and fewer wasted weeks on suboptimal treatment paths. The Precision Peptide Genetic Test adds $99 after your first month and maps genetic variants including GIPR rs1800437 and MC4R rs17782313 that predict your metabolic ceiling and optimal peptide combination.
Realistic Expectations: Avoiding the Comparison Trap
Social media and anecdotal reports often highlight exceptional results—people losing 3 pounds per week or 50 pounds in three months. These outcomes are real but represent the upper range of response, not the average. Most medically successful weight loss falls between 0.5 and 2 pounds per week over a year, and this pace is sustainable, protective of muscle, and supported by cardiovascular science.
Slower weekly loss often correlates with better long-term success because it reflects fat loss rather than muscle or water depletion. Research shows that sustainable weight loss (1 to 2 pounds per week) maintains lean muscle mass and metabolic rate better than rapid drops. If you are losing less than 0.5 pounds per week after 8 weeks on a stable therapeutic dose, your provider may adjust your medication, explore genetic barriers with the Precision Peptide Genetic Test, or review dietary adherence—all of which PlexusDx supports without additional costs.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight should I expect to lose per week when I start semaglutide?
Most patients lose 1 to 1.5 pounds per week during the first 8 to 12 weeks as appetite suppression takes effect. Weekly loss then stabilizes at 0.5 to 1 pound as your body adjusts. Initial drops often include water weight and are not purely fat loss.
Why did my weekly weight loss slow down after the first month?
Slower loss after month one is normal and reflects your body adapting to sustained reduced calorie intake. This deceleration is actually a sign of healthy, sustainable fat loss. Your provider can review adherence and dose to ensure you are on an effective maintenance level.
Is there a genetic test that can predict my weekly weight loss on semaglutide?
Yes. PlexusDx offers the Precision Peptide Genetic Test ($99 after your first month), which identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your individual response and optimal dose. This personalized insight helps your provider adjust your treatment faster for better results.
What if I am not losing weight at the expected rate?
Slower-than-expected loss may signal a need for dose adjustment, dietary review, or genetic exploration. PlexusDx providers can order the Precision Peptide Genetic Test to identify whether you might benefit from combination therapy (like GLP-Squared) or a different compound. Your dose may increase, but your monthly cost remains flat at $149 for semaglutide injection.
Does PlexusDx charge more if my dose goes up?
No. Compounded Semaglutide Injection from PlexusDx starts at $149 per month flat, and your price stays the same even if your therapeutic dose increases over time. This transparent pricing applies across all three commitment tiers, with no hidden per-dose charges.
Can I combine semaglutide with another medication to speed up weekly weight loss?
Yes. PlexusDx offers GLP-Squared Injection, which combines semaglutide and tirzepatide in one injection for enhanced appetite suppression and metabolism support. This dual-compound approach may accelerate weekly loss for patients who plateau on semaglutide alone, starting at $249 per month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do You Have to Prime the Ozempic Pen Every Time? A Comprehensive Guide
How Long Does It Take for GLP-1 to Take Effect?